发明名称 |
Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2 (1H)-indol-2-one (ziprasidone), its preparation and its use as dopamine D2 antagonist |
摘要 |
A method of treating a psychotic disorder, such as schizophrenia, in a non-human mammal comprising administering to the mammal an amount of a mesylate dihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one that is effective in the treatment of the psychotic disorder. |
申请公布号 |
NZ332218(A) |
申请公布日期 |
2005.02.25 |
申请号 |
NZ19970332218 |
申请日期 |
1997.04.10 |
申请人 |
PFIZER INC |
发明人 |
BUSCH, FRANK ROBERT;ROSE, CAROL ANNE;SHINE, RUSSELL JAMES |
分类号 |
A61K31/495;A61K31/496;A61P25/06;A61P25/18;A61P25/22;C07D417/12;(IPC1-7):C07D417/14 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|